Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC   ***UPDATED***
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC ***UPDATED***
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC ***UPDATED***
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - Tibra Trading PTY Limited: Hastings Group Holdings PLC
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Hardman & Co Research: City of London Investment Group (CLIG): Boost from positive markets and deal completion
Hardman & Co Research: City of London Investment Group (CLIG): Boost from positive markets and deal completion
Hardman & Co Research: City of London Investment Group (CLIG): Boost from positive markets and deal completion
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8 - The Vanguard Group, Inc.: Hastings Group Holdings plc
LogicBio announces pricing of public offering
LogicBio announces pricing of public offering
LogicBio announces pricing of public offering
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Hardman & Co Research: Arix Bioscience (ARIX): Realising the valuation disconnect
Hardman & Co Research: Arix Bioscience (ARIX): Realising the valuation disconnect
Hardman & Co Research: Arix Bioscience (ARIX): Realising the valuation disconnect
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Arix Bioscience PLC: Autolus presents additional AUTO3 data in DLBCL
Arix Bioscience PLC: Autolus presents additional AUTO3 data in DLBCL
Arix Bioscience PLC: Autolus presents additional AUTO3 data in DLBCL
Hardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase
Hardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase
Hardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Edison Investment Research Limited: Edison issues outlook on Raven Property Group (RAV)
Edison Investment Research Limited: Edison issues outlook on Raven Property Group (RAV)
Edison Investment Research Limited: Edison issues outlook on Raven Property Group (RAV)
Arix Bioscience PLC: Interim Results for the Six Months Ended 30 June 2020
Arix Bioscience PLC: Interim Results for the Six Months Ended 30 June 2020
Arix Bioscience PLC: Interim Results for the Six Months Ended 30 June 2020
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Hastings Group Holdings plc